Sampling and pharmacokinetics of skin interstitial fluid for therapeutically monitored drugs
To guide therapeutic decision making, the pharmacokinetics (PK) of certain toxic drugs are typically studied in blood. A drug’s blood concentration is thus acting as a surrogate for its target site concentration. However, a drug’s target is often extravascular and measuring tissue concentrations wou...
Main Author: | Schmitt, Veronika |
---|---|
Language: | English |
Published: |
University of British Columbia
2016
|
Online Access: | http://hdl.handle.net/2429/56176 |
Similar Items
-
Revolutionizing Therapeutic Drug Monitoring with the Use of Interstitial Fluid and Microneedles Technology
by: Tony K.L. Kiang, et al.
Published: (2017-10-01) -
Microneedle Arrays for Sampling and Sensing Skin Interstitial Fluid
by: Navid Kashaninejad, et al.
Published: (2021-04-01) -
Assays for Determination of Ertapenem for Applications in Therapeutic Drug Monitoring, Pharmacokinetics, and Sample Stability
by: Pickering, Matthew K., et al.
Published: (2014) -
Interstitial Fluid in Lipedema and Control Skin
Published: (2020-10-01) -
Pharmacokinetic changes and therapeutic drug monitoring of lamotrigine during pregnancy
by: Ye Ding, et al.
Published: (2019-07-01)